Acasti Pharma Insiders
ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Acasti Pharma employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Acasti Pharma's management performance can provide insight into the firm performance.
Janelle DAlvise CEO President CEO |
Acasti |
Acasti Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.1162) % which means that it has lost $0.1162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1856) %, meaning that it created substantial loss on money invested by shareholders. Acasti Pharma's management efficiency ratios could be used to measure how well Acasti Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Acasti Pharma Workforce Comparison
Acasti Pharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 465. Acasti Pharma claims roughly 9.0 in number of employees contributing just under 2% to equities under Health Care industry.
Acasti Pharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acasti Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acasti Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Acasti Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Olds Donald over three months ago Acquisition by Olds Donald of 12500 shares of Acasti Pharma at 2.64 subject to Rule 16b-3 | ||
Adar1 Capital Management, Llc over three months ago Discretionary transaction by Adar1 Capital Management, Llc of tradable shares of Acasti Pharma subject to Rule 16b-3 | ||
D'andrea Carrie over six months ago Acquisition by Dandrea Carrie of 19740 shares of Acasti Pharma at 2.96 subject to Rule 16b-3 | ||
Prashant Kohli over six months ago Acquisition by Prashant Kohli of 128770 shares of Acasti Pharma at 2.96 subject to Rule 16b-3 | ||
Delaversano Robert J over six months ago Acasti Pharma exotic insider transaction detected | ||
Davis A Brian over six months ago Acquisition by Davis A Brian of 22500 shares of Acasti Pharma subject to Rule 16b-3 | ||
George Kottayil over a year ago Acasti Pharma exotic insider transaction detected | ||
Kavuru Vimal over a year ago Purchase by Kavuru Vimal of 676371 shares of Acasti Pharma |
Acasti Pharma Notable Stakeholders
An Acasti Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Acasti Pharma often face trade-offs trying to please all of them. Acasti Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Acasti Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Janelle DAlvise | President CEO | Profile | |
Amresh Kumar | VP Management | Profile | |
Carrie DAndrea | VP Operations | Profile | |
George Kottayil | Chief US | Profile | |
Robert CPA | Principal Officer | Profile | |
Prashant Kohli | Chief Officer | Profile | |
Yves Lachance | VP Compliance | Profile | |
Pierre MD | COO CoFounder | Profile | |
Christine Pelletier | Director HR | Profile |
About Acasti Pharma Management Performance
The success or failure of an entity such as Acasti Pharma often depends on how effective the management is. Acasti Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acasti management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acasti management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Please note, the imprecision that can be found in Acasti Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acasti Pharma. Check Acasti Pharma's Beneish M Score to see the likelihood of Acasti Pharma's management manipulating its earnings.
Acasti Pharma Workforce Analysis
Traditionally, organizations such as Acasti Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Acasti Pharma within its industry.Acasti Pharma Manpower Efficiency
Return on Acasti Pharma Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.4M | |
Net Loss Per Executive | 1.4M | |
Working Capital Per Employee | 2.5M | |
Working Capital Per Executive | 2.5M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Global Correlations Find global opportunities by holding instruments from different markets |